AIM ImmunoTech Inc. (AIM)
USD 0.2
(-6.89%)
USD 0.2
(-6.89%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.60 USD | -36.36% |
| 2022 | -0.44 USD | 2.22% |
| 2021 | -0.45 USD | 11.76% |
| 2020 | -0.51 USD | 82.83% |
| 2019 | -2.97 USD | 69.6% |
| 2018 | -9.77 USD | 22.89% |
| 2017 | -12.67 USD | 16.26% |
| 2016 | -15.13 USD | 55.57% |
| 2015 | -34.05 USD | 30.41% |
| 2014 | -48.93 USD | 4.43% |
| 2013 | -51.20 USD | 21.21% |
| 2012 | -64.98 USD | -84.86% |
| 2011 | -35.15 USD | 32.08% |
| 2010 | -51.75 USD | 20.13% |
| 2009 | -64.79 USD | 24.54% |
| 2008 | -85.86 USD | 35.6% |
| 2007 | -133.32 USD | 19.54% |
| 2006 | -165.70 USD | -22.26% |
| 2005 | -135.53 USD | 51.96% |
| 2004 | -282.13 USD | -27.46% |
| 2003 | -221.34 USD | -81.17% |
| 2002 | -122.17 USD | 19.93% |
| 2001 | -152.58 USD | 1.16% |
| 2000 | -154.37 USD | 16.17% |
| 1999 | -184.14 USD | -8.98% |
| 1998 | -168.96 USD | 8.57% |
| 1997 | -184.80 USD | -19.59% |
| 1996 | -154.53 USD | -170.96% |
| 1995 | -57.03 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.12 USD | 53.85% |
| 2024 Q2 | -0.03 USD | 71.08% |
| 2023 Q4 | -0.26 USD | -62.5% |
| 2023 Q2 | -0.10 USD | -70.07% |
| 2023 Q3 | -0.16 USD | -60.0% |
| 2023 Q1 | -0.06 USD | 34.15% |
| 2023 FY | - USD | -36.36% |
| 2022 Q1 | -0.09 USD | 22.08% |
| 2022 FY | - USD | 2.22% |
| 2022 Q4 | -0.09 USD | 31.31% |
| 2022 Q3 | -0.13 USD | -30.0% |
| 2022 Q2 | -0.10 USD | -6.95% |
| 2021 Q3 | -0.08 USD | 33.33% |
| 2021 FY | - USD | 11.76% |
| 2021 Q4 | -0.12 USD | -50.0% |
| 2021 Q1 | -0.08 USD | 8.95% |
| 2021 Q2 | -0.12 USD | -53.26% |
| 2020 Q2 | -0.11 USD | 50.0% |
| 2020 Q4 | -0.09 USD | -1.18% |
| 2020 Q3 | -0.08 USD | 22.73% |
| 2020 FY | - USD | 82.83% |
| 2020 Q1 | -0.22 USD | -224.01% |
| 2019 Q2 | -1.07 USD | 63.23% |
| 2019 Q3 | -1.13 USD | -5.61% |
| 2019 FY | - USD | 69.6% |
| 2019 Q4 | -0.07 USD | 93.99% |
| 2019 Q1 | -2.91 USD | -99.32% |
| 2018 Q3 | -2.87 USD | -20.59% |
| 2018 Q1 | -3.29 USD | -35.95% |
| 2018 Q4 | -1.46 USD | 49.13% |
| 2018 FY | - USD | 22.89% |
| 2018 Q2 | -2.38 USD | 27.66% |
| 2017 Q2 | -3.53 USD | 27.96% |
| 2017 Q4 | -2.42 USD | -32.24% |
| 2017 Q1 | -4.90 USD | -128.97% |
| 2017 FY | - USD | 16.26% |
| 2017 Q3 | -1.83 USD | 48.16% |
| 2016 FY | - USD | 55.57% |
| 2016 Q1 | -4.62 USD | 30.94% |
| 2016 Q2 | -2.77 USD | 40.04% |
| 2016 Q3 | -5.77 USD | -108.3% |
| 2016 Q4 | -2.14 USD | 62.91% |
| 2015 Q3 | -8.14 USD | 24.84% |
| 2015 Q1 | -8.51 USD | 22.71% |
| 2015 Q4 | -6.69 USD | 17.81% |
| 2015 Q2 | -10.83 USD | -27.26% |
| 2015 FY | - USD | 30.41% |
| 2014 Q1 | -11.46 USD | -14.03% |
| 2014 Q4 | -11.01 USD | 5.41% |
| 2014 FY | - USD | 4.43% |
| 2014 Q2 | -14.09 USD | -22.95% |
| 2014 Q3 | -11.64 USD | 17.39% |
| 2013 Q1 | -11.43 USD | 33.85% |
| 2013 Q4 | -10.05 USD | 37.96% |
| 2013 FY | - USD | 21.21% |
| 2013 Q3 | -16.20 USD | -19.73% |
| 2013 Q2 | -13.53 USD | -18.37% |
| 2012 Q3 | -25.38 USD | -117.85% |
| 2012 Q2 | -11.65 USD | -29.88% |
| 2012 Q1 | -8.97 USD | 26.05% |
| 2012 Q4 | -17.28 USD | 31.91% |
| 2012 FY | - USD | -84.86% |
| 2011 Q3 | -10.68 USD | -19.33% |
| 2011 Q2 | -8.95 USD | -164.79% |
| 2011 Q1 | -3.38 USD | 59.95% |
| 2011 FY | - USD | 32.08% |
| 2011 Q4 | -12.13 USD | -13.58% |
| 2010 Q2 | -14.58 USD | 9.33% |
| 2010 Q3 | -12.74 USD | 12.62% |
| 2010 Q4 | -8.44 USD | 33.75% |
| 2010 Q1 | -16.08 USD | 0.0% |
| 2010 FY | - USD | 20.13% |
| 2009 Q4 | -16.08 USD | -59.84% |
| 2009 FY | - USD | 24.54% |
| 2009 Q1 | -20.42 USD | -5.97% |
| 2009 Q2 | -20.42 USD | 0.0% |
| 2009 Q3 | -10.06 USD | 50.73% |
| 2008 FY | - USD | 35.6% |
| 2008 Q4 | -19.27 USD | 19.94% |
| 2008 Q3 | -24.07 USD | -20.47% |
| 2008 Q1 | -22.62 USD | 7.3% |
| 2008 Q2 | -19.98 USD | 11.67% |
| 2007 Q2 | -28.71 USD | 26.63% |
| 2007 Q3 | -41.46 USD | -44.41% |
| 2007 Q1 | -39.13 USD | -11.07% |
| 2007 Q4 | -24.40 USD | 41.15% |
| 2007 FY | - USD | 19.54% |
| 2006 Q3 | -32.13 USD | 23.32% |
| 2006 FY | - USD | -22.26% |
| 2006 Q2 | -41.90 USD | 21.94% |
| 2006 Q4 | -35.23 USD | -9.65% |
| 2006 Q1 | -53.68 USD | -71.34% |
| 2005 Q1 | -37.87 USD | 2.57% |
| 2005 Q4 | -31.33 USD | -5.45% |
| 2005 FY | - USD | 51.96% |
| 2005 Q2 | -40.06 USD | -5.78% |
| 2005 Q3 | -29.71 USD | 25.84% |
| 2004 FY | - USD | -27.46% |
| 2004 Q1 | -104.41 USD | -98.95% |
| 2004 Q2 | -71.68 USD | 31.35% |
| 2004 Q3 | -78.61 USD | -9.67% |
| 2004 Q4 | -38.87 USD | 50.55% |
| 2003 FY | - USD | -81.17% |
| 2003 Q4 | -52.48 USD | 32.48% |
| 2003 Q3 | -77.73 USD | -33.76% |
| 2003 Q1 | -26.36 USD | -13.52% |
| 2003 Q2 | -58.11 USD | -120.45% |
| 2002 Q1 | -24.50 USD | 29.64% |
| 2002 Q4 | -23.22 USD | 25.36% |
| 2002 Q3 | -31.11 USD | 28.22% |
| 2002 Q2 | -43.34 USD | -76.9% |
| 2002 FY | - USD | 19.93% |
| 2001 Q2 | -41.09 USD | 5.99% |
| 2001 Q3 | -37.10 USD | 9.71% |
| 2001 Q4 | -34.82 USD | 6.15% |
| 2001 FY | - USD | 1.16% |
| 2001 Q1 | -43.71 USD | -0.76% |
| 2000 Q3 | -36.95 USD | 1.36% |
| 2000 FY | - USD | 16.17% |
| 2000 Q2 | -37.46 USD | -1.63% |
| 2000 Q1 | -36.86 USD | -0.33% |
| 2000 Q4 | -43.38 USD | -17.4% |
| 1999 FY | - USD | -8.98% |
| 1999 Q4 | -36.74 USD | 0.6% |
| 1999 Q3 | -36.96 USD | 30.0% |
| 1999 Q2 | -52.80 USD | 9.4% |
| 1999 Q1 | -58.28 USD | -13.89% |
| 1998 Q1 | -36.96 USD | -20.82% |
| 1998 Q2 | -36.96 USD | 0.0% |
| 1998 Q3 | -36.96 USD | 0.0% |
| 1998 FY | - USD | 8.57% |
| 1998 Q4 | -51.17 USD | -38.45% |
| 1997 Q2 | -36.96 USD | 50.0% |
| 1997 Q3 | -47.52 USD | -28.57% |
| 1997 FY | - USD | -19.59% |
| 1997 Q4 | -30.59 USD | 35.63% |
| 1997 Q1 | -73.92 USD | -69.39% |
| 1996 Q1 | -21.12 USD | -122.32% |
| 1996 Q4 | -43.64 USD | 17.35% |
| 1996 FY | - USD | -170.96% |
| 1996 Q3 | -52.80 USD | -42.86% |
| 1996 Q2 | -36.96 USD | -75.0% |
| 1995 Q4 | -9.50 USD | 40.03% |
| 1995 Q3 | -15.84 USD | 0.0% |
| 1995 Q1 | -15.84 USD | 0.0% |
| 1995 Q2 | -15.84 USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Ampio Pharmaceuticals, Inc. | -10.67 USD | 94.377% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | 68.586% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | 67.213% |
| Azitra, Inc. | -54.76 USD | 98.904% |
| Can-Fite BioPharma Ltd. | -1.79 USD | 66.48% |
| Chromocell Therapeutics Corporation | -1.28 USD | 53.125% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | 65.318% |
| CEL-SCI Corporation | -0.73 USD | 17.808% |
| iBio, Inc. | -6.50 USD | 90.769% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -400.0% |
| MAIA Biotechnology, Inc. | -1.49 USD | 59.732% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | 88.636% |
| Navidea Biopharmaceuticals, Inc. | -0.59 USD | -1.695% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 99.567% |
| NanoViricides, Inc. | -0.70 USD | 14.286% |
| Oragenics, Inc. | -9.18 USD | 93.464% |
| BiomX Inc. | -5.10 USD | 88.235% |
| BiomX Inc. | -5.10 USD | 88.235% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 600.0% |
| Palatin Technologies, Inc. | -2.02 USD | 70.297% |
| Scorpius Holdings, Inc. | -347.20 USD | 99.827% |